Bone Marrow Derived AC 133+ and Mono-Nuclear Cells (MNC) Implantation in Myocardial Infarction (MI) Patient

NCT01187654 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

80

Enrollment

OTHER_GOV

Sponsor class

Conditions

Myocardial Infarction

Interventions

BIOLOGICAL: AC133
BIOLOGICAL: MNC
BIOLOGICAL: CONTROL

Sponsor

Royan Institute